Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform

Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform

For the efficacy of COVID-19 vaccines, emergence of variants accumulating immune-escape mutations remains a major concern. We analyzed the anti-variant (n = 10) neutralization activity of sera from COVID-19 patients infected with Wuhan (B.1), Kappa, and Delta variants and COVISHIELD vaccine recipien...

Full description

Bibliographic Details
Main Authors: Rajashree Patil, Sonali Palkar, Akhileshchandra Mishra, Rahul Patil, Vidya Arankalle
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
COVISHIELD
MSD
SARS-COV-2 variants
immunogenicity
ACE2 neutralization
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1181991/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1181991/full

Similar Items